References– Victoria Angel Registry of Hope

Aird W., et al. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Bone Marr Trans 1992; 9:487-90.

Ballen KK, Spitzer TR, Yeap B, Steve M, Dey BR, Attar E et al. Excellent disease-free survival after double cord blood transplantion using a reduced intensity chemotherapy only conditioning regimen in a diverse adult population. ASH Annual Meeting Abastracts 2005; 106: 2048.

Barker JN, Weisdorf DJ, DeFor TE et al. Transplantation of 2 partially HLA matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105:1343-1347.

Bhatia M, Walters M. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant, 2008; 41:109-17.

Boelens JJ, Aldenhoven M, Purtill D,et al. Eurocord; Inborn Errors Working Party of European Blood and Marrow Transplant group; Duke University Blood and Marrow Transplantation Program; Centre for International Blood and Marrow Research. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013;121:3981-7.

Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc National Acad Sci USA 2003; 100: 645– 50.

Carroll J. Human cord blood for the hypoxic-ischemic neonate. Pediatr Res. 2012;71:459-63.

Chhabra P, Brayman KL. Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med.

2013;2:328-36. Review.
CLINICAL TRIAL: Duke University, Neonatal Hypoxic Ischemic Encephalopathy; Phase 1 Clinical trial NCT00593242 (Accessed July 31, 2013)

Cutler C, Ballen KK.  Improving outcomes in umbilical cord blood transplantation: state of the art. Blood Rev. 2012;26:241-6. Review.

Da Costa V, O’Grady G, Jackson L, Kaylie D, Raynor E. Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis. Arch Otolaryngol Head Neck Surg. 2012;138:1071-6.

Eapen M, Rubinstein P, Zhang JM et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 2007; 369: 1947–1954.

Escolar ML, Poe MD, Provenzale JM et al. Transplantion of umbilical cord blood in babies with infantile Krabbe’s disease. NEJM 2005; 352: 2069-2081.

Fiorina P, Voltarelli J, Zavazava N. Immunological applications of stem cells in type 1 diabetes. Endocr Rev. 2011;32:725-54.

Franqoul H et al. Unrelated UCB transplantation in children with immune deficiency: results of a multicenter study. Bone Marrow Transplant 2009, Jun

Frey M et al. Umbilical cord blood cell transplantation. Semin Oncol Nurs 2009 May; 25(2): 115 -9.

Fruchtman SM, Hurlet A, Dracker R et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol Blood Marrow Transplant, 2004; 10: 741-2.

Garbuzova-Davis S. et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE. 2008 June 25; 3(6).

Garbuzova-Davis S, Rodrigues MC, Mirtyl S et al. Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS. PLoS One. 2012;7:e31254.

Gluckman E, Koegler G, Rocha V. Human leukocyte antigen matching in cord blood transplantation. Semin Hematol 2005; 42: 85-90.

Gluckman E, Rocha V, Arcese W, Michael G, Sanz G, Chan KW et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.

Goldstein G, Toren A, Nagler A. Transplantation and other uses of human umbilical cord blood and stem cells. Curr Pharm Des, 2007; 13:1363-73.

Haller, M.J. et al. Autologous umbilical cord blood infusion for type 1 diabetes. Exp. Hematology. 2008; 36: 710-715.

Harris D, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007; 2:301-309.

Hau S, Reich D, Scholz M et al. Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci, 2008; 9:30.

Hayani A, et al. First report of autologous cord blood transplantation in treatment of a child with leukemia. Pediatrics. 2007; 119:296-300.

Jubert C, Wagner E, Bizier S, Vachon MF, Duval M, Champagne M. Length of cord blood unit cryopreservation does not impact hematopoietic engraftment. Transfusion 2008; 48:2028-29.

Kobylka, P. “Preservation of Immunological and Colony-Forming Capacities of Long-Term (15 years) Cryopreserved Cord Blood Stem Cells. Transplantation”. 1998;65 (9):1275-1278.

Koestenbauer S et al. Protocols for Hematopoietic stem cell expansion from UCB. Cell Transplant 2009 May 6: CT-2012.

Kurtzberg et al. Update on umbilical cord blood transplantation. Current Opinion Pediatrics, 2009 Feb: 21(1): 22-9.

Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study: clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematological malignancies. Blood 2008; 112: 4318-4327.

Kwon M, Balsalobre P, Serrano SD, et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2013 ;19:143-9.

Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J Med 2001; 344: 1815–1822.

Liao Y, Geyer MB, Yang AJ, Cairo MS. Cord blood transplantation and stem cell regenerative potential. Exp Hematol. 2011;39:393-412.

Lichtenstein, P., et al. “Environmental and Heritable Factors in the Causation of Cancer”. New England Journal of Medicine. 2000;343 (2):78-85.

Liu H, Rich ES, Godley L et al. Reduced-intensity conditioning with combined haploidentical and cord blood
transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118:6438-45.
Locatelli F, Kabbara N, Ruggeri A, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013 May 21. [Epub ahead of print]

Majhail N, Weisdorf D, Wagner J et al. Comparable results of umbilical cord blood and HLA-matched sibling donor preparative regimen for advanced Hodgkin lymphoma. Blood, 2006; 107: 3804-7.

Martin HR, Poe MD, Provenzale JM et al. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant. 2013;19:616-24.

Nagler A. Recent Developments in human ucb transplantation in Israel. Biol Blood Marrow Transplant 2008, Jan; 14:99-103.

Neitfeld J, Pasquini M, Logan B, Verter F, Horowitz M. Lifetime probabilities of hematopoietic stem cell transplantation in the US. 2008; 13:316-22.

Newman M Davis C, Borlongan C et al. Transplantion of human umbilical cord blood cells in the repair of CNS diseases. Expert Opin. Biol Ther 2004; 4:121-30.

Okamura K et al. Successful Cord Blood Transplantation using a reduced-intensity conditioning regimen for advanced childhood-onset cerebral adrenoleukodystrophy. Pediatric Transplant, 2009 May; 13:130-133.

Pasquini MC et al. The likelihood of hematopoietic stem cell transplantation (HCT) in the United States: implications for umbilical cord blood storage. Blood 2005; 11.

Reedberg, L. “Cancer Rates for Children Worry Experts”. San Francisco Chronicle. September 17, 1997.

Rocha V, Chastang C, Souillet G et al. Related cord blodo transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group, Bone Marrow Transplant, 1998; 21 (supple. 3): 559-62.

Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients, Bone Marrow Transplant, 2008; 41:207-14.

Rocha V, Labopin M, Ruggeri A et al. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies. Transplantation. 2013;95:1284-91.

Rosenkranz K, Meier C Umbilical cord blood cell transplantation after brain ischemia–from recovery of function to cellular mechanisms. Ann Anat. 2011;193:371-9.

Sandberg P et al. Umbilical cord blood derived stem cells and brain repair, Ann NY Acad Sci 2005: 1049:67-83.

Scaradavou A, Brunstein CG, Eapen M et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013;121:752-8.

Shenoy S. Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants. Stem Cells Transl
Med. 2013;2:337-40.

Silversides A. Cord Blood Bank plans evolve with ‘glacial speed”. Published in Canadian Medical Association Journal (CMAJ), 2009 Jun 23; 180(13): 1295-6.

Staba SL, Escolar ML, Poe M, et al. Cord blood transplants from unrelated donors in patients with Hurler’s syndrome.
NEJM 2004; 305: 1960-1969.

Urban C, Schwinger W Benesch M et al. Autologous cord blood transplantation in children with acute lymphoblastic leukemia and central nervous system relapse, Pediatrics, 2007; 119: 1042 -43.

Van Besien K, Liu H, Jain N, Stock W, Artz A. Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications. Biol Blood Marrow Transplant. 2013;19:682-91.

Wagner E, Duval M, Dalle JH, Morin H, Bizier S, Champagne J, Champage MA. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 2006; 46:1190-8.

Wagner J, Kernan N, Steinbuch M, et al. Allogeneic sibling umbilical cord blood transplantion in children with malignant and non-malignant disease. Lancet 1995; 346: 214 -219.

Willert J, Purdon T, Harris D. Umbilical Cord Blood – Biology, Banking and Therapeutic Use. US Obstetrics and

Gynecology – Neonatal Medicine. 2008.

Willert, J. Low risk of transplant-related complications with genetically related cord blood stem cells. 2008; ASBMT

Annual meeting presentation.
Willing A, Eve D, Sanbertg P. Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective. Regen Med, 2007; 2:457 -64

World Marrow Donor Association (WMDA) Annual Report, 2006 – 2011

Zietlow R et al. et al. Transplantation of Human Umbilical cord blood cells in the repair of CNS diseases. Expert Opin Biol Ther. 2004, Feb; 4(2): 121-30.